Viewing Study NCT04120493


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-02-25 @ 5:51 PM
Study NCT ID: NCT04120493
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-21
First Post: 2019-09-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease
Sponsor: UniQure Biopharma B.V.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Huntington's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gene therapy View
None AAV (adeno-associated virus) View
None serotype 5 AAV (adeno-associated virus) View
None serotype 5 View
None Viral vector View
None miHTT View
None muHTT View
None Huntington's Disease (HD) View